Logo

Home

smallArrow

Stocks Screener

smallArrow

Brooks Laboratories

Brooks Laboratories Share Price

Brooks Laboratories (INR)147.47-3   (-2%)

Exchange ScripsBSE533543NSEBROOKSISININE650L01011

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Brooks Laboratories Performance

Market performance
Open price147.47
High147.47
Volumes25940
Prev Close147.47
Low147.47
Closing date2024-09-20
Historical performance
1 Year High185.70
3 Year High185.70
5 Year High185.70
1 Year Low73.25
3 Year Low56.95
5 Year Low13.72

Brooks Laboratories Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
274
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
-17.43
Dividend Yield
Dividend Yield
N/A

Brooks Laboratories Investment Returns

1 Year
48.4%
3 Years
9.4%
5 Years
377.7%
10 Years
333%

Brooks Laboratories Technicals

IndicatorsValueSignal
5-DMA153.62Bearish
10-DMA151.48Bearish
20-DMA138.61Bullish
50-DMA115.19Bullish
100-DMA101.94Bullish
200-DMA114.31Bullish

Shareholding Pattern

FieldJun-2024Mar-2024Dec-2023Sep-2023Jun-2023
Promoters99999
Foreign Investors---------------
Domestic Investors99999
Public Investors1153411423100191067711207
Government---------------

Brooks Laboratories Financials

Below figures are in Rs. Crores

ParticularsMar-2023Mar-2022Mar-2021
Other Income287
Operating Profit-262-13413
Interest223131
Depreciation707471
Profit Before Tax-384-239-90
Consolidated Net Profit-209-113-194
Adjusted EPS-8-5-8

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2023Mar-2022Mar-2021
Share Capital247247247
Total Reserves493628544
Minority Interest---468---
Total Non-Current Liabilities26114193
Total Liabilities109619461621
Capital Work in Progress---1517
Total Assets109619461621

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities-145-37445
Cash Flow from Investing Activities5-249-51
Cash Flow from Financing Activitie11464112
Net Cash Inflow / Outflow-26175
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of -17.43.
  • 3Y Stock Price CAGR of the stock is 4.4.
  • The stock has a beta of 0.7.
  • In the last financial year, the company had an EBITDA of ₹-262 Million.
  • The company generated revenue of ₹632 Million in the previous financial year.

Brooks Laboratories

147.47-3   (-2%)

Investment Amount: ₹ 9745
Current Value: ₹ 14747
Performence: 51.3%
P/L: ₹ 5002
Top Gainers
SymbolChange%
ITDCEM562.45(19%)
MARKSANS318.35(16%)
CONCORDBIO2601.1(16%)
MAGADSUGAR957.45(14%)
PRSMJOHNSN219.54(12%)
Top Losers
SymbolChange%
ROSSELLIND170.85(-73%)
SADHNANIQ59.21(-9%)
BHARATRAS11914.5(-7%)
PEARLPOLY42.08(-7%)
SAKSOFT276.15(-7%)
AGIIL1042.6(-6%)
GATECH1.17(-6%)
XTGLOBAL41.63(-6%)
Similar stocks

Panacea Biotec

▲ 62.2

314.09

August 20 - September 20

Concord Biotech

▲ 57.1

2601.1

August 20 - September 20

Marksans Pharma

▲ 44.3

318.35

August 20 - September 20

Syncom Formulations

▲ 39.5

22.71

August 20 - September 20

Wanbury

▲ 38.6

278.79

August 20 - September 20

Jubilant Pharmova

▲ 34.5

1206.1

August 20 - September 20

Nectar Lifesciences

▲ 29.9

42.25

August 20 - September 20

Biofil Chem & Pharma

▲ 29.7

83.6

August 20 - September 20

Announcing Stock of the Month!

 

Phone

Registered Users

10 lacs

Google Rating

4.6